Abstract # 2498 A Phase I Study to Assess the Ability of the Anti-cytokine Agent Thalidomide to Modulate Radiation-Induced Lung Injury

Presenter: Anscher, Mitchell

< Back to topics

> Cover Page, Authors, Institutions

> Purpose/Objective

> Materials/Methods

> Results/Discussion

> Conclusions

> View tables/images/videos

M. S. Anscher*, J. Garst*, L. B. Marks*, N. Larrier*, F. Dunphy*, J. E. Herndon*, R. Clough*, C. Marino*, Z. Vujaskovic*, S. Zhou*. , et al., Duke University Medical Center, Durham, NC,

Author Disclosure:
M.S. Anscher, Celgene Corp, B. Research Grant; J. Garst, None; L.B. Marks, None; N. Larrier, None; F. Dunphy, None; J.E. Herndon, None; R. Clough, None; C. Marino, None; Z. Vujaskovic, None; S. Zhou, None.

E-mail a friend about this abstract:
Enter email address:   

Abstracts Main Page | Logout